Blatam

This study is testing a two-part treatment for people with high-risk bladder cancer that has not responded well to the standard BCG therapy. Participants will receive a chemotherapy wash directly into the bladder every 3 weeks, combined with an IV immunotherapy drug every 6 weeks…